Topic Hub
24 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 24 of 24 clinical reviews.
A physician-reviewed, week-by-week guide to alendronate (Fosamax) in the first month, covering GI side effects, dosing technique, bone-marker changes, and what improvement actually looks like at 4 weeks.
Read clinical reviewDoes alendronate (Fosamax) affect appetite or food cravings? A physician-reviewed, evidence-based breakdown of GI mechanisms, clinical trial data, and practical management for patients taking alendronate for osteoporosis.
Read clinical reviewA physician-reviewed, evidence-based guide to alendronate (Fosamax) use in patients with autoimmune diseases, covering bisphosphonate interactions with immune function, GI risk, osteonecrosis, and dosing decisions.
Read clinical reviewA clinician-level review of how alendronate (Fosamax) improves bone mineral density and reduces fracture risk, covering FIT trial data, dosing, monitoring, and safety considerations.
Read clinical reviewA clinician-level review of the cancer risk signals associated with alendronate (Fosamax), covering esophageal, breast, colorectal, and osteosarcoma data, with citations to primary trials and FDA communications.
Read clinical reviewA physician-reviewed deep dive into the long-term cardiovascular effects of alendronate (Fosamax), covering clinical trial data, mechanisms, atrial fibrillation risk, and what current guidelines recommend.
Read clinical reviewA clinician-level review of alendronate (Fosamax) and cognitive function, covering mechanistic hypotheses, observational data, and what current guidelines say about bisphosphonate use in older adults.
Read clinical reviewA clinical deep-dive comparing compounded alendronate to branded Fosamax, including bioavailability data, FDA regulatory standing, FIT trial evidence, and guidance on when each formulation is appropriate.
Read clinical reviewA physician-level review of alendronate (Fosamax) evidence graded by GRADE methodology, covering FIT, FIT Long-Term, FOSIT, and current guideline recommendations for osteoporosis treatment.
Read clinical reviewA physician-reviewed deep dive into alendronate (Fosamax) hair and skin side effects, including postmarketing case reports, mechanism, and clinical management guidance.
Read clinical reviewA clinician-level review of alendronate (Fosamax) and its reported effects on mood, depression, anxiety, and cognitive function, with primary-literature citations and a practical monitoring framework.
Read clinical reviewA physician-level review of how alendronate (Fosamax) is absorbed, distributed, metabolized, and excreted, plus a careful look at whether bisphosphonate therapy affects resting energy expenditure, thermogenesis, or body composition.
Read clinical reviewA physician-reviewed deep dive into alendronate microdosing protocols, standard dosing evidence, fracture-reduction data from FIT and other trials, and where reduced-dose regimens stand in current osteoporosis guidelines.
Read clinical reviewEvidence-based muscle preservation strategies for patients on alendronate (Fosamax), covering exercise protocols, nutrition timing, drug interactions, and monitoring parameters supported by primary literature.
Read clinical reviewWhy alendronate (Fosamax) stops working, how to confirm true non-response versus poor adherence, and when to switch therapies. MD/PharmD-level depth with primary-literature citations.
Read clinical reviewAlendronate after bariatric surgery carries significant absorption and tolerability risks. Learn which patients qualify, what alternatives exist, and how current guidelines approach bisphosphonate therapy in post-bariatric bone management.
Read clinical reviewA clinician-level guide to the alendronate pre-surgery hold window: when to pause Fosamax, how long bone binding lasts, fracture risk versus surgical risk, and the current 2024 guideline consensus.
Read clinical reviewA physician-level review of what happens to bone turnover, fracture risk, and BMD when you stop alendronate (Fosamax), including drug holiday timing, rebound data, and restart criteria.
Read clinical reviewA clinician-level review of alendronate (Fosamax) and the kidneys: pharmacokinetics, renal clearance, CKD dosing thresholds, evidence from FIT and post-market data, and practical monitoring guidance.
Read clinical reviewWhen and how to safely restart alendronate (Fosamax) after acute illness, hospitalization, or a medication hold. MD-level guidance with primary literature, dosing protocols, and monitoring frameworks.
Read clinical reviewA clinician-level guide to alendronate (Fosamax) seasonal use considerations, including vitamin D status, patient adherence patterns, and fracture-risk management across all four seasons.
Read clinical reviewDoes alendronate (Fosamax) affect sexual function? A physician-reviewed deep dive into the clinical evidence, mechanisms, and what patients and prescribers need to know.
Read clinical reviewA physician-reviewed deep dive into how alendronate (Fosamax) affects sleep architecture, REM cycles, and overnight bone turnover markers, with primary-literature citations throughout.
Read clinical reviewBoard-reviewed protocols for taking alendronate (Fosamax) during travel, long-haul flights, and timezone crossings. Covers missed-dose rules, posture requirements at altitude, and real-world scheduling fixes backed by primary literature.
Read clinical review